No Data
No Data
Earnings Preview: CHRS to Report Financial Results Post-market on November 06
Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024
Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR) and Coherus Biosciences (CHRS)
The Market Doesn't Like What It Sees From Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Revenues Yet As Shares Tumble 28%
Coherus BioSciences Inc (CHRS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
JonesTrading Maintains Coherus BioSciences(CHRS.US) With Buy Rating
No Data
No Data